Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | AGXT | P21549 | 2/20 | 0.44 |
| ▸ | MAP2K4 | P45985 | 1/20 | 0.43 |
| ▸ | NOS3 | P29474 | 1/20 | 0.43 |
| ▸ | NOS1 | P29475 | 1/20 | 0.43 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.42 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | VHL | P40337 | 1/20 | 0.41 |
| ▸ | ELOC | Q15369 | 1/20 | 0.41 |
| ▸ | ELOB | Q15370 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21114374 | 0.97 | IDO1 (0.52) | IDO1TSHRACHETDP1CYP1A2 | |
| SCHEMBL3337 | 0.97 | — | — | |
| SCHEMBL585056 | 0.94 | IDO1 (0.50) | IDO1TSHRACHETDP1CYP1A2 | |
| SCHEMBL586331 | 0.94 | IDO1 (0.50) | IDO1TSHRACHETDP1CYP1A2 | |
| Methane SCHEMBL27627149 | 0.94 | IDO1 (0.50) | IDO1TSHRACHETDP1CYP1A2 | |
| Ammonia Solution, Strong SCHEMBL28235889 | 0.94 | IDO1 (0.50) | IDO1TSHRACHETDP1CYP1A2 | |
| Alcohol SCHEMBL1568943 | 0.92 | IDO1 (0.48) | IDO1TSHRACHETDP1CYP1A2 | |
| Trimethylammonium SCHEMBL9858163 | 0.89 | IDO1 (0.46) | IDO1TSHRACHETDP1CYP1A2 | |
| SCHEMBL258820 | 0.89 | MAP2K4 (0.49) | IDO1TSHRACHETDP1CYP1A2 | |
| SCHEMBL8992802 | 0.89 | SRD5A2 (0.50) | IDO1TSHRACHETDP1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8119749-B2 | Method of taking (meth)acrylic ester polymer out of liquid reaction mixture | KURARAY CO., LTD. (JP) | 2012-02-21 | — | — | US | disclosed |
| EP-1916262-B1 | METHOD OF TAKING (METH)ACRYLIC ESTER POLYMER OUT OF LIQUID REACTION MIXTURE | KURARAY CO (JP) | 2012-02-15 | — | — | EP | disclosed |
| US-7973117-B2 | Milder temperatures, higher speed; controlled molecular weight and narrow distribution thermoplastic elastomers | KURARAY CO., LTD. (JP) | 2011-07-05 | — | — | US | disclosed |
| US-20090118450-A1 | METHOD OF TAKING (METH)ACRYLIC ESTER POLYMER OUT OF LIQUID REACTION MIXTURE | KURARAY CO., LTD. (JP) | 2009-05-07 | — | — | US | disclosed |
| EP-1780222-B1 | PROCESS FOR CONTINUOUSLY PRODUCING (METH)ACRYLIC ESTER POLYMER OR COPOLYMER | KURARAY CO (JP) | 2008-11-26 | — | — | EP | disclosed |
| US-20080139759-A1 | Process For Continuously Producing (Meth)Acrylic Ester Polymer or Copolymer | KURARAY CO., LTD. (JP) | 2008-06-12 | — | — | US | disclosed |
| EP-1916262-A1 | METHOD OF TAKING (METH)ACRYLIC ESTER POLYMER OUT OF LIQUID REACTION MIXTURE | Kuraray Co., Ltd. (JP) | 2008-04-30 | — | — | EP | disclosed |
| EP-1780222-A1 | PROCESS FOR CONTINUOUSLY PRODUCING (METH)ACRYLIC ESTER POLYMER OR COPOLYMER | KURARAY CO., LTD. (JP) | 2007-05-02 | — | — | EP | disclosed |
| EP-0523100-B1 | O6 -BENZYLATED GUANINE, GUANOSINE AND 2'-DEOXYGUANOSINE COMPOUNDS POSSESSING O6 -ALKYLGUANINE-DNA ALKYLTRANSFERASE DEPLETING ACTIVITY | US HEALTH (US) | 1996-08-28 | — | — | EP | disclosed |
| US-5358952-A | Anticarcinogenic agents | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-10-25 | — | — | US | disclosed |
| US-5352669-A | Increases host responsiveness to anti-neoplastic alkylating agents including chloroethylating agents for chemotheraputical treatment | THE OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-10-04 | — | — | US | disclosed |
| EP-0523100-A4 | O?6 -BENZYLATED GUANINE, GUANOSINE AND 2'-DEOXYGUANOSINE COMPOUNDS POSSESSING O?6 -ALKYLGUANINE-DNA ALKYLTRANSFERASE DEPLETING ACTIVITY | US HEALTH (US) | 1993-03-17 | — | — | EP | disclosed |
| EP-0523100-A1 | O?6 -BENZYLATED GUANINE, GUANOSINE AND 2'-DEOXYGUANOSINE COMPOUNDS POSSESSING O?6 -ALKYLGUANINE-DNA ALKYLTRANSFERASE DEPLETING ACTIVITY. | US HEALTH (US) | 1993-01-20 | — | — | EP | disclosed |
| US-5091430-A | Increase response to antitumor agents | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1992-02-25 | — | — | US | disclosed |
| WO-1991013898-A1 | O6-BENZYLATED GUANINE, GUANOSINE AND 2'-DEOXYGUANOSINE COMPOUNDS POSSESSING O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE DEPLETING ACTIVITY | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, UNITED STATES DEPARTMENT OF COMMERCE (US) | 1991-09-19 | — | — | WO | disclosed |